COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,066,800 | +64.2% | 820,000 | +87.4% | 0.01% | -14.3% |
| Q2 2023 | $1,868,125 | -9.0% | 437,500 | +45.8% | 0.01% | +55.6% |
| Q1 2023 | $2,052,000 | +72.7% | 300,000 | +100.0% | 0.01% | -25.0% |
| Q4 2022 | $1,188,000 | +5.9% | 150,000 | -3.2% | 0.01% | +50.0% |
| Q2 2022 | $1,122,000 | +132.8% | 155,000 | +416.7% | 0.01% | +14.3% |
| Q3 2021 | $482,000 | -59.0% | 30,000 | -64.7% | 0.01% | -50.0% |
| Q2 2021 | $1,176,000 | -13.0% | 85,000 | -8.1% | 0.01% | -17.6% |
| Q1 2021 | $1,351,000 | +63.8% | 92,500 | +105.6% | 0.02% | +41.7% |
| Q3 2020 | $825,000 | -34.0% | 45,000 | -35.7% | 0.01% | -45.5% |
| Q2 2020 | $1,250,000 | +71.2% | 70,000 | +55.6% | 0.02% | +22.2% |
| Q1 2020 | $730,000 | +0.6% | 45,000 | +11.6% | 0.02% | +12.5% |
| Q4 2019 | $726,000 | -19.8% | 40,340 | -59.7% | 0.02% | +33.3% |
| Q4 2018 | $905,000 | +254.9% | 100,000 | +334.1% | 0.01% | +140.0% |
| Q1 2018 | $255,000 | -91.2% | 23,035 | -84.1% | 0.01% | -96.0% |
| Q3 2015 | $2,911,000 | – | 145,261 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |